(Q67282782)

English

Clinical efficacy and safety of a new leuprorelin acetate depot formulation in patients with advanced prostatic cancer

scientific article published on 01 January 1990

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2108886

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2108886%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

title

Clinical efficacy and safety of a new leuprorelin acetate depot formulation in patients with advanced prostatic cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2108886

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2108886%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1 reference

O' Brien A

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2108886

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2108886%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

Hibberd M

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2108886

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2108886%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

publication date

1 January 1990

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2108886

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2108886%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

published in

Journal of International Medical Research

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2108886

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2108886%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

volume

18 Suppl 1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2108886

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2108886%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

page(s)

57-68

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2108886

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2108886%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

Identifiers

DOI

10.1177/03000605900180S109

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2108886

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2108886%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 September 2019

PubMed publication ID

2108886

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2108886

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2108886%20AND%20SRC:MED&resulttype=core&format=json

(Q67282782)

Clinical efficacy and safety of a new leuprorelin acetate depot formulation in patients with advanced prostatic cancer

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)